Cipro Suspension/ Drops
Product Images NDC 76420-273

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cipro (NDC 76420-273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ciprofloxacin Chemical Structure (Ciprohc 01)

Chemical structure of ciprofloxacin hydrochloride, illustrating its molecular framework including a fluorine-substituted bicyclic ring and multiple nitrogen-containing groups.*

FDA Label Image

Hydrocortisone Chemical Structure (Ciprohc 02)

Chemical structure diagram of hydrocortisone, one of the active ingredients in CIPRO HC (ciprofloxacin hydrochloride and hydrocortisone) otic suspension/drops by Asclemed USA, Inc.*

FDA Label Image

Principal Display Panel Ndc 0078-0855-26 Cipro® Hc Otic (ciprofloxacin 0.2% Hci And Hydrocortisone 1% Otic Suspension) Not For Ophthalmic Or Oral Use Rx O (Ciprohc 03)

Label for Cipro HC Otic, a suspension/drops containing ciprofloxacin hydrochloride and hydrocortisone, relabeled by Enovachem Pharmaceuticals and distributed by Novartis Pharmaceuticals Corp. The label includes NDC 76420-273-10, a quantity of 10, and federal caution statements regarding prescription status and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.